BioElectronics Corporation has appointed Dr. Deepak Kotak MA (Oxford), MBBS, FRCA, MRCP, LLDip, LLM as Executive Vice President. With the appointment of Dr. Kotak who lives in London, BioElectronics will have a greater presence in Europe to further promote the ActiPatch Therapy product line that is available OTC in Boots. Prior to his appointment, Dr. Kotak has been Chief Medical Officer of TraumaTec, a Houston medical device company as well as a consultant to the Boss Group and Blackstone Valley Group, two private equity firms.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -33.33% | -50.00% | -50.00% |
Mar. 25 | BioElectronics Corporation Announces the Results and Publication of A Canine Arthritis Study | CI |
Feb. 23 | Bioelectronics Corporation Announces the Publication of Pilot Study Results | CI |
1st Jan change | Capi. | |
---|---|---|
-50.00% | 2.47M | |
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
-0.04% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |
- Stock Market
- Equities
- BIEL Stock
- News BioElectronics Corporation
- BioElectronics Appoints Deepak Kotak as Executive Vice President